SCHEMBL965913

SCHEMBL965913

CC(=N)OC(=O)[C@@H](N)CCCCN

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.50
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
CPB2 Q96IY4 4/20 0.39
DPP7 Q9UHL4 7/20 0.38
DPP8 Q6V1X1 3/20 0.38
DPP9 Q86TI2 3/20 0.38
DPP4 P27487 1/20 0.36
RNPEP Q9H4A4 1/20 0.36
PAOX Q6QHF9 1/20 0.35
TLR2 O60603 1/20 0.35
NOS3 P29474 2/20 0.34
NOS1 P29475 2/20 0.34
NOS2 P35228 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL964384 0.95 GSR (0.42) GSRGNAI3GNAO1GNAI1CPB2
Hydrochloric Acid SCHEMBL28698703 0.93 GSR (0.41) GSRGNAI3GNAO1GNAI1CPB2
SCHEMBL124168 0.85 GSR (0.53) GSRGNAI3GNAO1GNAI1CPB2
SCHEMBL7112527 0.85 GSR (0.53) GSRGNAI3GNAO1GNAI1CPB2
SCHEMBL1404247 0.85 GSR (0.61) GSRGNAI3GNAO1GNAI1CPB2
SCHEMBL20240364 0.85 GSR (0.61) GSRGNAI3GNAO1GNAI1CPB2
SCHEMBL344574 0.85 GSR (0.61) GSRGNAI3GNAO1GNAI1CPB2
SCHEMBL7936567 0.84 GSR (0.52) GSRGNAI3GNAO1GNAI1CPB2
Water SCHEMBL28009501 0.84 GSR (0.52) GSRGNAI3GNAO1GNAI1CPB2
SCHEMBL680614 0.83 GSR (0.59) GSRGNAI3GNAO1GNAI1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140154207-A1 KIT CONTAINING STEM CELLS AND CYTOKINES FOR USE IN ATTENUATING IMMUNE RESPONSES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-05 US claimed
CN-115697383-A Methods of treating viral infections and health problems 艾伦·戴维多夫 2023-02-03 CN disclosed
CN-104721824-A Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation OMEROS CORP 2015-06-24 CN disclosed
US-8476196-B2 Control of harmful algal blooms by induction of programmed cell death UNIVERSITY OF SOUTH FLORIDA (US) 2013-07-02 US disclosed
US-20110021357-A1 CONTROL OF HARMFUL ALGAL BLOOMS BY INDUCTION OF PROGRAMMED CELL DEATH UNIVERSITY OF SOUTH FLORIDA (US) 2011-01-27 US disclosed
US-20050142217-A1 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype QUEEN'S UNIVERSITY AT KINGSTON (CA) 2005-06-30 US disclosed
EP-1278547-A2 FORMULATIONS AND METHODS OF USING NITRIC OXIDE MIMETICS AGAINST A MALIGNANT CELL PHENOTYPE QUEEN'S UNIVERSITY AT KINGSTON (CA) 2003-01-29 EP disclosed
EP-1267862-A2 METHODS AND COMPOSITIONS FOR IMPROVING SLEEP Cellegy Canada Inc. (CA) 2003-01-02 EP disclosed
WO-2001080890-A2 FORMULATIONS AND METHODS OF USING NITRIC OXIDE MIMETICS AGAINST A MALIGNANT CELL PHENOTYPE QUEEN'S UNIVERSITY AT KINGSTON (CA) 2001-11-01 WO disclosed
WO-2001062290-A2 METHODS AND COMPOSITIONS FOR IMPROVING SLEEP CELLEGY CANADA INC. (CA) 2001-08-30 WO disclosed